Literature DB >> 12958393

The St-Louis du Parc Heart Health Project: a critical analysis of the reverse effects on smoking.

L Renaud1, J O'Loughlin, V Déry.   

Abstract

OBJECTIVES: Although some school based smoking prevention programmes have shown positive impacts, others have had only short term effects, no effects, and in some cases reverse effects. The St-Louis du Parc Heart Health Project was a five year heart health promotion programme targeting children in eight elementary schools aged 9-12 years in disadvantaged multiethnic neighbourhoods in Montreal. In a controlled, longitudinal evaluation, the programme produced reverse effects on smoking--children exposed to the programme were more likely to initiate and to continue smoking than control children. This article explores hypotheses to explain the reverse effects.
DESIGN: Following work by an in-house committee, a consensus workshop with international experts was conducted to develop hypotheses to explain the reverse effects. This was complemented by an analysis of the programme's concordance with the standard guidelines on the school based prevention of tobacco use, and discussions with experts at the Centers for Disease Control and Prevention.
RESULTS: The programme respected most standard guidelines for smoking prevention programmes with respect to content and mode of delivery. Hypotheses to explain the reverse effects include: an unfavourable environment characterised by strong pro-smoking models and resistance to environmental interventions; heightened sensitivity to smoking among children most exposed to the programme; defence mechanisms among children stimulated by cognitive dissonance or anxiety; unanticipated effects associated with the health educator who delivered the programme; inadequate attention in programme development to the diverse cultural origins of the population targeted; and intervention content inappropriately targeted to children's stages of cognitive development.
CONCLUSION: Elementary school based interventions should aim to develop a clear and coherent social norm about the non-use of tobacco, as a precursor to or in close conjunction with having children as their primary target. Programme design should take key student characteristics into consideration and ensure that the modes of communication are adapted to the targeted group's characteristics. Neighbourhood level interventions should be orchestrated to complement regional, provincial, and national programmes.

Entities:  

Mesh:

Year:  2003        PMID: 12958393      PMCID: PMC1747750          DOI: 10.1136/tc.12.3.302

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  47 in total

1.  Two-year behavior outcomes of project towards no tobacco use.

Authors:  C W Dent; S Sussman; A W Stacy; S Craig; D Burton; B R Flay
Journal:  J Consult Clin Psychol       Date:  1995-08

2.  Outcomes of the Minnesota Smoking Prevention Program.

Authors:  N H Hamm
Journal:  Psychol Rep       Date:  1994-10

3.  Evaluating the evaluators: a reply to Hawthorne et al.

Authors:  R Wheller
Journal:  Addiction       Date:  1995-02       Impact factor: 6.526

4.  Eleven components of effective drug abuse prevention curricula.

Authors:  L Dusenbury; M Falco
Journal:  J Sch Health       Date:  1995-12       Impact factor: 2.118

5.  Long-term follow-up results of a randomized drug abuse prevention trial in a white middle-class population.

Authors:  G J Botvin; E Baker; L Dusenbury; E M Botvin; T Diaz
Journal:  JAMA       Date:  1995-04-12       Impact factor: 56.272

6.  Tobacco use measurement, prediction, and intervention in elementary schools in four states: the CATCH Study.

Authors:  J P Elder; C L Perry; E J Stone; C C Johnson; M Yang; E W Edmundson; M H Smyth; T Galati; H Feldman; P Cribb; G S Parcel
Journal:  Prev Med       Date:  1996 Jul-Aug       Impact factor: 4.018

7.  The social impact of Life Education: estimating drug use prevalence among Victorian primary school students and the statewide effect of the Life Education programme.

Authors:  G Hawthorne
Journal:  Addiction       Date:  1996-08       Impact factor: 6.526

8.  Parent participation in an adolescent drug abuse prevention program.

Authors:  D A Cohen; K L Linton
Journal:  J Drug Educ       Date:  1995

9.  Nutrition and physical activity program to attenuate obesity and promote physical and metabolic fitness in elementary school children.

Authors:  J E Donnelly; D J Jacobsen; J E Whatley; J O Hill; L L Swift; A Cherrington; B Polk; Z V Tran; G Reed
Journal:  Obes Res       Date:  1996-05

10.  A controlled evaluation of a fitness and nutrition intervention program on cardiovascular health in 10- to 12-year-old children.

Authors:  R Vandongen; D A Jenner; C Thompson; A C Taggart; E E Spickett; V Burke; L J Beilin; R A Milligan; D L Dunbar
Journal:  Prev Med       Date:  1995-01       Impact factor: 4.018

View more
  5 in total

1.  Milestones in the natural course of onset of cigarette use among adolescents.

Authors:  André Gervais; Jennifer O'Loughlin; Garbis Meshefedjian; Christina Bancej; Michèle Tremblay
Journal:  CMAJ       Date:  2006-08-01       Impact factor: 8.262

2.  [Beauty and smoking: the utilization of public health programs in the prevention of tobacco use disorders].

Authors:  Christine Lacroix; Nathalie Auger
Journal:  Can J Public Health       Date:  2007 Sep-Oct

3.  The role of urban municipal governments in reducing health inequities: A meta-narrative mapping analysis.

Authors:  Patricia A Collins; Michael V Hayes
Journal:  Int J Equity Health       Date:  2010-05-25

Review 4.  School-based programmes for preventing smoking.

Authors:  Roger E Thomas; Julie McLellan; Rafael Perera
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

5.  Comparing effects of tobacco use prevention modalities: need for complex system models.

Authors:  Steve Sussman; David Levy; Kristen Hassmiller Lich; Crystal W Cené; Mimi M Kim; Louise A Rohrbach; Frank J Chaloupka
Journal:  Tob Induc Dis       Date:  2013-01-22       Impact factor: 2.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.